Oric Pharmaceuticals, Inc. ($ORIC)
Filing Information
| Accession Number | 0001695028-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 28, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
231,000
Total Value
$1,430,534.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 26, 2026 | Exercise/Conversion | 52,000 | $4.36 | $226,720.00 | 121,828 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 26, 2026 | Exercise/Conversion | 25,000 | $6.00 | $150,000.00 | 146,828 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 26, 2026 | Sale | 77,000 | $13.69 | $1,053,814.30 | 69,828 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Aug 26, 2026 | Exercise/Conversion | 52,000 | $0.00 | $0.00 | 92,500 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Aug 26, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 120,000 | Direct | โ | View Details |